What question did this study set out to answer?

To investigate how glucocorticoids regulate bone metabolism and explore genetic and pharmacological strategies to prevent bone loss.

Recent advances in glucocorticoid regulation of bone and the bone marrow niche: genetic and pharmacological approaches to understand and prevent bone loss

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial explores glucocorticoid effects on bone loss and interventions in human bone health, suggesting innovative therapeutic avenues.

To investigate how glucocorticoids regulate bone metabolism and explore genetic and pharmacological strategies to prevent bone loss.
Examined glucocorticoid effects on osteoblasts, osteocytes, and osteoclasts through targeted signaling pathways.
Analyzed the role of extracellular vesicles in mediating glucocorticoid-induced bone changes.
Identified potential pharmacological agents that target Wnt signaling to mitigate bone loss.
Excess glucocorticoids significantly reduce osteogenesis and increase marrow adiposity, affecting bone density.
Therapeutic compounds demonstrated promise in counteracting the negative impacts of glucocorticoids on bone health.
Emerging findings suggest that niche-derived extracellular vesicles could offer new therapeutic strategies against bone loss.

Hermsmeyer et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial explores glucocorticoid effects on bone loss and interventions in human bone health, suggesting innovative therapeutic avenues.